Drugs / Oridonin
Oridonin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05130892 | Nov 2021 → Feb 2023 | — | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oridonin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05130892 ↗ |
| Known as | Isodonol | ChEMBL registry synonym — accepted as the source's own label CHEMBL1164920 ↗ |
| Known as | NSC-250682 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1164920 ↗ |
| Known as | Oridonine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1164920 ↗ |
| Known as | Pure oridonin | ChEMBL registry synonym — accepted as the source's own label CHEMBL1164920 ↗ |
| Modality | Small molecule | — CHEMBL1164920 ↗ |